中国人群初治激素敏感性前列腺癌的TP53改变特征
该研究对94例中国局限性初治激素敏感性前列腺癌(HNPC)样本行靶向二代测序,并与临床结局关联。结果显示TP53改变频率较高(21/94),且与Wnt信号通路改变相关;TP53与Wnt/CTNNB1改变互斥,KMT2C改变更易与TP53共现,提示侵袭性表型及PARP抑制剂敏感性。
要点
- 中国HNPC中TP53改变频率为21/94,与Wnt通路改变相关。
- TP53与Wnt/CTNNB1改变互斥,KMT2C改变常与TP53共现。
- 仅CDH1改变与快速生化复发(BCR)相关。
核心结论
- TP53改变检测对中国HNPC精准治疗有临床价值。
研究设计与样本
- 研究对94例中国原发性局限性HNPC样本行靶向二代测序,并关联临床结局。
主要发现
- PTEN、CDK12和SPOP改变频率与西方人群相似。
- TP53改变频率为21/94,Wnt信号通路改变频率为15/94。
- LRP1B改变占比较高,CDH1改变在中国PCa中更频繁。
- 仅CDH1改变与快速生化复发(BCR)相关。
- TP53改变与Wnt/CTNNB1改变互斥,KMT2C改变更易与TP53共现。
临床怎么用
- 对HNPC患者检测TP53改变可能有助于指导精准治疗选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prostate cancer (PCa) shows racial disparity in clinical and genomic characteristics, and Asian patients with PCa often present with more aggressive phenotypes at diagnosis. The ability of TP53 to serve as a prognostic biomarker of PCa has been well studied in Western populations. However, no studies to date have examined the role of TP53 in the disparities of primary hormone-naïve prostate cancer (HNPC) between Chinese and Western populations. METHODS: We collected prostate tumors and matched normal tissues or blood samples to perform targeted next-generation sequencing of 94 Chinese primary localized HNPC samples, and correlated these genomic profiles with clinical outcomes. The OncoKB knowledge database was used to identify and classify actionable alterations. RESULTS: The aberrations of PTEN, CDK12, and SPOP in Chinese HNPC samples were similar to those in the Western samples. However, we demonstrated an association of a high frequency of TP53 alterations (21/94) with a relatively higher percentage of alterations in the Wnt signaling pathway (15/94) in Chinese HNPC. Additionally, we highlighted alterations of LRP1B as accounting for a high proportion of PCa and found more frequent alterations in CDH1 in Chinese PCa. Of these, only CDH1 alteration was associated with rapid biochemical recurrence (BCR). However, we verified that TP53 status was at the core of the genomic alteration landscape in Chinese HNPC with putative driver mutations because of the strong connections with other signaling pathways. The mutually exclusive relationship between alterations in TP53 and Wnt/CTNNB1 further molecularly characterizes subsets of prostate cancers. Moreover, the alteration of KMT2C was more likely to co-occur with TP53 alteration, indicating a more aggressive phenotype of PCa, which was associated with sensitivity to treatment with poly ADT-ribose polymerase (PARP) inhibitors. CONCLUSIONS: Detection of TP53 alterations has clinical utility for guiding precision cancer therapy for HNPC, especially in the Chinese population.
引用
- Liu Z, Guo H, Zhu Y, et al. TP53 alterations of hormone-naïve prostate cancer in the Chinese population. Prostate Cancer Prostatic Dis. 2020. PMID: 33214693. doi:10.1038/s41391-020-00302-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。